Presentación clínica del Hemangiosarcoma (HSA) en caninos y sus tratamientos.
| dc.contributor.advisor | Ponce Cepeda, Edison Vicente | |
| dc.contributor.author | Rodríguez Vera, Lilisbeth Alejandra | |
| dc.date.accessioned | 2022-11-16T19:53:54Z | |
| dc.date.available | 2022-11-16T19:53:54Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | http://dspace.utb.edu.ec/handle/49000/13322 | |
| dc.description | Making a diagnosis of hemangiosarcoma (HSA) is usually too slow, this is because it is a type of pathology of last evaluation, since there are several diseases that resemble in symptomatology. Hemangiosarcoma (HSA) is a type of vascular endothelial cell cancer that arises in the internal organs, especially in the spleen and heart, it is very difficult to detect. The clinical signs are nonspecific that pet owners do not realise the disease until the tumour breaks down and the affected dogs are taken to an emergency unit due to the consequences of blood loss in the internal cavity of the body. A diagnosis of HSA leads to a very poor prognosis because it has no cure and most dogs survive less than a year. After the preparation of the literature review and the study of the cases exposed, it is concluded that the breeds with the most predisposition are medium and large, elderly, although HSA has no predilection for sex, although a certain prevalence has been observed in males. In most clinical presentations of the HSA, the splenic one stands out due to the high metastasis it presents. Regarding the way to combat the disease, we have that, even using methods such as chemotherapy, with which good results are obtained, surgery is still the most used. It is also concluded that, HSA is not a typical neoplasm since it has an aggressiveness and destructive power above any other type of disease, the rate or time of survival with surgery range from 30 to 120 days while with the application of chemotherapy they reach up to 11 months, in any case it depends a lot on the conditions in which the disease is detected and the treatment that is performed. | es_ES |
| dc.description | Making a diagnosis of hemangiosarcoma (HSA) is usually too slow, this is because it is a type of pathology of last evaluation, since there are several diseases that resemble in symptomatology. Hemangiosarcoma (HSA) is a type of vascular endothelial cell cancer that arises in the internal organs, especially in the spleen and heart, it is very difficult to detect. The clinical signs are nonspecific that pet owners do not realise the disease until the tumour breaks down and the affected dogs are taken to an emergency unit due to the consequences of blood loss in the internal cavity of the body. A diagnosis of HSA leads to a very poor prognosis because it has no cure and most dogs survive less than a year. After the preparation of the literature review and the study of the cases exposed, it is concluded that the breeds with the most predisposition are medium and large, elderly, although HSA has no predilection for sex, although a certain prevalence has been observed in males. In most clinical presentations of the HSA, the splenic one stands out due to the high metastasis it presents. Regarding the way to combat the disease, we have that, even using methods such as chemotherapy, with which good results are obtained, surgery is still the most used. It is also concluded that, HSA is not a typical neoplasm since it has an aggressiveness and destructive power above any other type of disease, the rate or time of survival with surgery range from 30 to 120 days while with the application of chemotherapy they reach up to 11 months, in any case it depends a lot on the conditions in which the disease is detected and the treatment that is performed. | es_ES |
| dc.description.abstract | Realizar un diagnóstico de hemangiosarcoma (HSA) por lo general es demasiado lento, esto es debido a que es un tipo de patología de última valoración, pues existen varias enfermedades que se asemejan en sintomatología. El hemangiosarcoma (HSA) es un tipo de cáncer de células endoteliales vasculares que surge en los órganos internos, especialmente en el bazo y el corazón, es muy difícil de detectar. Los signos clínicos son inespecíficos por lo que los propietarios de las mascotas no se dan cuenta de la enfermedad hasta que el tumor se rompe y los perros afectados son llevados a una unidad de emergencia debido a las consecuencias de la pérdida de sangre en la cavidad interna del cuerpo. Un diagnóstico de HSA conlleva un pronóstico muy pobre debido a que no tiene cura y la mayoría de los perros sobreviven menos de un año. Tras la elaboración de la revisión bibliográfica y el estudio de los casos expuestos se concluye que, las razas con más predisposición son las medianas y grandes, de edad avanzada, aunque la HSA no tiene predilección por sexo, aunque se ha observado cierta prevalencia en machos. En la mayoría de las presentaciones clínica del HSA destaca la esplénica debido a la alta metástasis que presenta. Respecto al modo de combatir la enfermedad tenemos que, incluso empleando métodos como la quimioterapia, con la que se obtienen buenos resultados, aún sigue siendo la cirugía la más empleada. Se concluye también que, el HSA no es una neoplasia típica ya que posee una agresividad y poder destructivo por encima de cualquier otro tipo de enfermedad, la tasa o tiempo de supervivencia con cirugía oscilan entre 30 y 120 días mientras que con la aplicación de quimioterapia llegan hasta los 11 meses, en todo caso depende mucho de las condiciones en las que se llegue a detectar la enfermedad y el tratamiento que se realice para así mejorar la calidad de vida del paciente. | es_ES |
| dc.format.extent | 24 p. | es_ES |
| dc.language.iso | es | es_ES |
| dc.publisher | BABAHOYO: UTB, 2022 | es_ES |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Ecuador | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ec/ | * |
| dc.subject | Neoplasia | es_ES |
| dc.subject | Hemangiosarcoma (HSA) | es_ES |
| dc.subject | Caninos | es_ES |
| dc.subject | Cáncer. | es_ES |
| dc.title | Presentación clínica del Hemangiosarcoma (HSA) en caninos y sus tratamientos. | es_ES |
| dc.type | bachelorThesis | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Ecuador